Shabnam Vaezzadeh, MD, MPA, BCMAS

CEO, Global Medial Executive, Exquisite Biomedical Consulting

Areas of expertise: Medical Affairs, Market Adoption, KOLs and Advisory Boards, Publication and Clinical Strategy, Safety, Due Diligence, Start Up Advising and Value Proposition, EU MDR Clinical Evaluation

Additional area of support: Quality and ISO 13485

Current role: CEO, Global Medial Executive, Exquisite Biomedical Consulting

Dr. Vaezzadeh offers over 22 years of corporate experience in leadership of Product Safety, Medical Affairs, Clinical Development, and a background in due diligence for business development in Medical Devices and Regenerative Medicine. She has held leadership roles in companies such as LifeScan (Johnson and Johnson), KCI (Acelity, 3M) and Organogenesis. She is the founder of Exquisite Biomedical Consulting (EBC) with 7 years of experience consulting in the industry.

Shabnam’s background spans working with a variety of technologies and therapeutic areas including diabetes, wound healing, regenerative medicine, abdominal wall repair, breast reconstruction, orthopedics and sports medicine, general surgery, neuromodulation, and cardiology.

Shabnam has extensive experience with Clinical Evaluation Reports for EU MDR including CERs, CEPs, PMCF and SSCP documents.

Shabnam advises start-up CEOs, accelerators, investors and small to mid-size companies with due diligence, enhancing value proposition and building a compelling business case from the medical and clinical perspective.